166 related articles for article (PubMed ID: 34781817)
1. Human umbilical vein endothelial cells derived-exosomes promote osteosarcoma cell stemness by activating Notch signaling pathway.
Yang J; Hu Y; Wang L; Sun X; Yu L; Guo W
Bioengineered; 2021 Dec; 12(2):11007-11017. PubMed ID: 34781817
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling.
Yu L; Fan Z; Fang S; Yang J; Gao T; Simões BM; Eyre R; Guo W; Clarke RB
Oncotarget; 2016 May; 7(22):33055-68. PubMed ID: 27102300
[TBL] [Abstract][Full Text] [Related]
3. TSG attenuates LPC-induced endothelial cells inflammatory damage through notch signaling inhibition.
Zhao J; Liang Y; Song F; Xu S; Nian L; Zhou X; Wang S
IUBMB Life; 2016 Jan; 68(1):37-50. PubMed ID: 26662286
[TBL] [Abstract][Full Text] [Related]
4. Exosomes derived from human umbilical vein endothelial cells promote neural stem cell expansion while maintain their stemness in culture.
Zhang YZ; Liu F; Song CG; Cao XL; Zhang YF; Wu HN; Guo CJ; Li YQ; Zheng QJ; Zheng MH; Han H
Biochem Biophys Res Commun; 2018 Jan; 495(1):892-898. PubMed ID: 29154990
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein.
Sun Z; Wang L; Zhou Y; Dong L; Ma W; Lv L; Zhang J; Wang X
Cell Mol Neurobiol; 2020 Jul; 40(5):767-784. PubMed ID: 31853695
[TBL] [Abstract][Full Text] [Related]
6. Exosomes Derived from Hypoxia-Treated Human Adipose Mesenchymal Stem Cells Enhance Angiogenesis Through the PKA Signaling Pathway.
Xue C; Shen Y; Li X; Li B; Zhao S; Gu J; Chen Y; Ma B; Wei J; Han Q; Zhao RC
Stem Cells Dev; 2018 Apr; 27(7):456-465. PubMed ID: 29415626
[TBL] [Abstract][Full Text] [Related]
7. Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling.
Estupiñán Ó; Rey V; Tornín J; Murillo D; Gallego B; Huergo C; Blanco-Lorenzo V; Victoria González M; Rodríguez A; Moris F; González J; Ayllón V; Ramos-Mejía V; Bigas A; Rodríguez R
Biomed Pharmacother; 2023 Jun; 162():114627. PubMed ID: 37018985
[TBL] [Abstract][Full Text] [Related]
8. Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells.
Debeb BG; Cohen EN; Boley K; Freiter EM; Li L; Robertson FM; Reuben JM; Cristofanilli M; Buchholz TA; Woodward WA
Breast Cancer Res Treat; 2012 Jul; 134(2):495-510. PubMed ID: 22547109
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of rapamycin on endothelial-to-mesenchymal transition in HUVECs through the Notch signaling pathway.
Tian D; Zeng X; Wang W; Wang Z; Zhang Y; Wang Y
Vascul Pharmacol; 2019 Feb; 113():20-26. PubMed ID: 30336218
[TBL] [Abstract][Full Text] [Related]
10. Exosomal CLIC1 released by CLL promotes HUVECs angiogenesis by regulating ITGβ1-MAPK/ERK axis.
Geng HY; Feng ZJ; Zhang JJ; Li GY
Kaohsiung J Med Sci; 2021 Mar; 37(3):226-235. PubMed ID: 32841520
[TBL] [Abstract][Full Text] [Related]
11. OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway.
Wang H; Wang L; Zhou X; Luo X; Liu K; Jiang E; Chen Y; Shao Z; Shang Z
Biomed Res Int; 2020; 2020():2125656. PubMed ID: 32695810
[TBL] [Abstract][Full Text] [Related]
12. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
BMC Vet Res; ; . PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
